BUZZ-U.S. STOCKS ON THE MOVE-Aeropostale, Apollo, GW Pharma

(Adds Pioneer Energy, GW, American Eagle, Aeropostale; Updates Constellation Brands (NYSE: STZ - news) , AbbVie (Xetra: 4AB.DE - news) ) (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

U.S. stock index futures rose on Thursday, putting equities on track for a second day of gains after the S&P 500 snapped a five-day losing skid and ahead of data on the labor market. Dow Jones industrial average futures were up 0.95 percent at 17,673, S&P 500 futures were up 0.84 percent at 2,036.5 and Nasdaq 100 futures were up 0.86 percent at 4,187.

** AMERICAN EAGLE OUTFITTERS INC (NYSE: AEO - news) , Wednesday close $14.63

** AEROPOSTALE INC, Wednesday close $2.26, +7.08 pct premarket

The teen apparel retailers raised their estimates for the holiday shopping quarter as margins improved due to fewer discounts.

** PIONEER ENERGY SERVICES CORP (NYSE: PES - news) , Wednesday close $4.89

The oilfield services company said it received early termination notices for contracts for four rigs in the first quarter, as oil companies continue to cut back on capital spending.

The company also said it expected to idle seven more rigs in the next month, with two more going offline by the end of the quarter.

** GW PHARMACEUTICALS PLC (NasdaqGM: GWPH - news) , Wednesday close $71.055, -2.34 pct premarket

An experimental cannabis drug failed to alleviate pain in cancer patients as hoped in a clinical study. GW Pharmaceuticals , which is developing the drug Sativex for pain in collaboration with Japan's Otsuka Corp, said the first of three late-stage trials found no statistically significant difference between subjects using its product and those given a placebo.

** CONSTELLATION BRANDS INC, Wednesday close $103.05, +3.83 pct premarket

The alcoholic beverage maker raised its full-year earnings forecast after reporting higher-than-expected quarterly sales and profit, helped by increased sales of its beer brands such as Corona and Modelo.

** ABBVIE INC, Wednesday close $66.93, +1.66 pct premarket

** NEUROCRINE BIOSCIENCES INC (NasdaqGS: NBIX - news) , Wednesday close $21.88, +26.37 pct premarket

An experimental drug being developed by AbbVie and Neurocrine successfully reduced symptoms of endometriosis in pre-menopausal women in the first of two late-stage studies.

** APOLLO EDUCATION GROUP, Wednesday close $31.86, -13.06 pct premarket

The for-profit education provider's quarterly profit plunged nearly 66 percent as student enrollments fell. New (KOSDAQ: 160550.KQ - news) degreed enrollments at Apollo's flagship University of Phoenix (LSE: PHNX.L - news) fell 5 percent to 39,600 in the first quarter.

** INFINITY PHARMA, Wednesday close $16.33, -11.27 pct premarket

The company said it would stop testing its lead drug as a treatment for rheumatoid arthritis after it failed the main goal in a mid-stage study. Duvelisib - being developed with AbbVie Inc in oncology - will still be tested to treat various types of blood cancer.

** IMPAX LABORATORIES INC (NasdaqGS: IPXL - news) , Wednesday close $30.99, +10.55 pct premarket

The company said the U.S. Food and Drug Administration had approved Rytary, its drug for treating Parkinson's disease, which was previously rejected due to issues with the company's manufacturing plant in Hayward, California. The agency had also raised concerns about Impax's factory in Taiwan.

** MANNKIND CORP (NasdaqGM: MNKD - news) , Wednesday close $5.65, +5.13 pct premarket

The drugmaker said it earned $50 million in milestone payments from Sanofi SA related to its licensing deal with the French drugmaker.

** GENERAL MOTORS CO, Wednesday close $35.84, +0.64 pct premarket

The carmaker's luxury Cadillac brand has cut the price most customers will pay for its 2015 CTS (Taiwan OTC: 3672.TWO - news) to counter slumping demand in the United States for the marquee sedan.

** NOVARTIS AG (Xetra: 904278 - news) , Wednesday close $92.07, +2.34 pct premarket

The Swiss pharma group said it will submit regulatory applications in the United States for two treatments against chronic obstructive pulmonary disease after late-stage clinical studies yielded good results.

** H&R BLOCK INC (NYSE: HRB - news) , Wednesday close $32.56, +1.32 pct premarket

The tax preparer said it expects a boost from new U.S. tax forms required under President Barack Obama's healthcare law and from new clients seeking the company's help, Chief Executive Officer Bill Cobb told Reuters on Wednesday.

** SANCHEZ ENERGY CORP, Wednesday close $7.97, +3.76 pct premarket

The oil producer operating in Texas and Mississippi, cut its 2015 capital budget on Wednesday by 60 percent, citing a recent drop in crude oil prices.

** LULULEMON ATHLETICA INC (NasdaqGS: LULU - news) , Wednesday close $57.65, +0.95 pct premarket

The Canadian yoga wear maker on Wednesday named Stuart Haselden chief financial officer, replacing long-time executive John Currie who announced in June his plan to retire by the end of the fiscal year.

** HALOZYME THERAPEUTICS INC (NasdaqGS: HALO - news) , Wednesday close $12.52, +3.35 pct premarket

The drugmaker believes it has a multibillion-dollar cancer drug on its hands. The drug, PEGPH20, being tested against pancreatic cancer, has the potential to help treat several other types of solid tumor cancers, its chief executive said in an interview.

** COSTCO WHOLESALE CORP, Wednesday close $144.32, +1.18 pct premarket

The warehouse club operator's December sales rose 5 percent to $12.12 billion. Comparable sales for the month was up 3 percent, while comparable sales, excluding fuel was up 8 percent.

** PORTUGAL TELECOM SGPS SA, Wednesday close $0.8601, -3.49 pct premarket

Portugal Telecom has said next week's shareholder meeting to approve the sale of its former assets by merger partner Oi (NYSE: OIBR - news) will take place as planned, quashing media speculation the vote might be postponed and boosting its shares.

** STATOIL ASA (Xetra: 675213 - news) , Wednesday close $16.74, +0.96 pct premarket

The Norwegian oil and gas producer will continue to make dividend payments a top priority even though oil prices have fallen more steeply than it expected, forcing it to be selective over projects, its acting CEO said.

** BIND THERAPEUTICS INC (NasdaqGS: BIND - news) , Wednesday close $5.15, +46.41 pct premarket

The drug developer said it enrolled its first patient in a mid-stage trial on lung cancer drug BIND-014. The Trial will focus on lung cancer patients with KRAS mutant, who have historically been unresponsive to standard treatment. Bind also attained milestone as part of agreement with Pfizer Inc (NYSE: PFE - news)

** INSULET CORP, Wednesday close $44.53, -7.37 pct premarket

The medical device maker slashed its fourth-quarter revenue estimate, citing delays in shipments of its non-insulin drug delivery products from the fourth quarter of 2014 to the first quarter of 2015.

The company now expects fourth-quarter revenue of $71 million-$73 million, down from its previous forecast of $76 million-$81 million.

** BIODEL INC (NasdaqCM: BIOD - news) , Wednesday close $1.45, +33.79 pct premarket

The drug developer's preliminary mid-stage trial results showed that its experimental insulin drug may be more effective than Eli Lilly and Co therapies in controlling glucose in patients when dosed immediately before breakfast.